Photo by Jeremy Bezanger on Unsplash

The Cepi vaccine initiative aims to raise more than three billion euros. It relies on mRNA technology and the biotech company Moderna. In the article, Head of IBES Prof. Dr. Markus Scholz comments on Moderna’s patent release: “It is a positive step that Moderna is taking and a necessary step also to share the technological know-how. A patent release alone is not sufficient.”

The full article here.